The gene expression change of MDA-MB-231 treated with HDAC/G4 dual-targeting compound
Ontology highlight
ABSTRACT: The HDAC/G4 dual compound a6 was developed to improve G4 targeting efficiency and anticancer activity in triple-negative breast cancer cells. In order to explore the relationship between G4 functions and a6 treatment, we performed RNA-seq to analyze the proportion of G4-related differentially expressed genes and KEGG pathway enrichment.
ORGANISM(S): Homo sapiens
PROVIDER: GSE188629 | GEO | 2022/11/30
REPOSITORIES: GEO
ACCESS DATA